AcuCort AB
ACUC
Rank in Stocks
#29049
Specializing in pharmaceutical innovation, AcuCort AB (publ) focuses on the... Specializing in pharmaceutical innovation, AcuCort AB (publ) focuses on the development and commercialization of glucocorticoid dexamethasone film products, particularly for acute allergic conditions. Among its offerings is Zeqmelit, a medication with diverse therapeutic uses. Zeqmelit addresses severe and acute allergic reactions, pediatric croup, chemotherapy-induced nausea and vomiting, and also serves as a treatment for COVID-19 patients who require supplemental oxygen. The company, established in 2006, is headquartered in Lund, Sweden.
Share Price
$0.03841665
Last synced: 2026-11-09
Market Cap
$9.01M
Change (1 day)
-7.88%
Change (1 year)
-39.24%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade AcuCort AB (ACUC)
Category
Healthcare
EPS for AcuCort AB (ACUC)
EPS as of June 2026 TTM: $-0.01
According to AcuCort AB's latest financial reports, its current EPS (TTM) is $-0.01. At the end of 2025 the company had an EPS of $-0.02, a decrease compared to its 2024 EPS of $-0.01.
EPS history for AcuCort AB from 2016 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.01 | -29.50% |
| 2025 | $-0.02 | 118.35% |
| 2024 | $-0.01 | -31.45% |
| 2023 | $-0.02 | -56.32% |
| 2022 | $-0.04 | 13.75% |
| 2021 | $-0.03 | -11.85% |
| 2020 | $-0.04 | 5.83% |
| 2019 | $-0.03 | -28.69% |
| 2018 | $-0.05 | -6.42% |
| 2017 | $-0.05 | 166.32% |
| 2016 | $-0.02 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | -46,209.22% |
DE
|
|
| $6.08 | -43,203.55% |
DE
|
|
| $1.55 | -11,097.16% |
JP
|
|
| $3.66 | -26,057.45% |
CH
|
|
| $0.45 | -3,291.49% |
IL
|
Questions about AcuCort AB's earnings per share (EPS)
What is AcuCort AB's earnings per share (EPS)?
AcuCort AB's earnings per share (EPS) over the last twelve months is $-0.01, as of Jun 2026.
What was AcuCort AB's earnings per share (EPS) in 2025?
In 2025, AcuCort AB's earnings per share (EPS) was $-0.02, compared with $-0.01 in 2024.
How has AcuCort AB's earnings per share (EPS) changed since 2020?
From 2020 to 2025, AcuCort AB's earnings per share (EPS) was highest in 2024 ($-0.01) and lowest in 2022 ($-0.04).
How does AcuCort AB's earnings per share (EPS) compare with similar companies?
AcuCort AB's earnings per share (EPS) ($-0.01) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.